BioFocus extends Roche alliance
BioFocus has entered into an agreement with Switzerland's Roche for the design of a several custom kinase libraries for use in the latter's drug discovery efforts.
Archives for September 30, 2003
Silica venture in Japan
Degussa and Shionogi set up a new joint venture company in Japan to sell precipitated silica, silica gel and matting agents, used as pharmaceutical additives.
deCODE up on obesity gene find
Iceland's deCODE Genetics saw its US-listed shares rise more than 10 per cent yesterday after it reported the discovery of a gene that appears to play a role in whether people are lean or fat.
Elan in pact with BMS
Embattled Elan has signed a deal with BMS that will see its NanoCrystal drug delivery technology applied to a number of the latter's drug candidates.
Casburt unveils in-house tablet press
UK company Casburt has introduced a new own-brand, medium-output range of tabletting machines under the Technipress banner.
CTD creates review backlog in UK
The UK MHRA admits to delays in the processing of marketing applications because of a huge number of files submitted ahead of new EU legislation.
Chemicals follow crops as Bayer reorganises
Germany's Bayer has continued the revamp of its business units by setting up its chemicals, technology services and healthcare activities as three separate legal entities. The move follows the carve-out of Bayer CropScience a year ago.
Image analysis from Amersham
Amersham Biosciences has introduced a new software package designed for the analysis of images from a wide range of biological samples.
EGFtk blocker from Roche disappoints
Another drug targeting epidermal growth factor tyrosine kinase - Roche's Tarceva, has failed to live up to early promise as a treatment for lung cancer.